Chemed (NYSE:CHE) Downgraded to “Hold” Rating by Wall Street Zen

Chemed (NYSE:CHE) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Monday.

CHE has been the subject of several other research reports. Royal Bank Of Canada increased their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Oppenheimer lowered their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Finally, Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Chemed presently has an average rating of “Hold” and an average target price of $501.50.

Chemed Price Performance

NYSE:CHE opened at $440.67 on Monday. Chemed has a one year low of $365.20 and a one year high of $565.66. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The stock has a market cap of $5.85 billion, a PE ratio of 24.01, a P/E/G ratio of 1.66 and a beta of 0.54. The stock has a 50 day moving average price of $409.41 and a 200 day moving average price of $424.51.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter last year, the firm earned $5.63 earnings per share. The business’s revenue for the quarter was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities research analysts expect that Chemed will post 22.3 EPS for the current fiscal year.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.33% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Chemed

Several institutional investors and hedge funds have recently modified their holdings of CHE. Monetary Solutions Ltd acquired a new position in Chemed during the 4th quarter worth about $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed in the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC grew its position in Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after acquiring an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. purchased a new stake in Chemed during the fourth quarter worth about $27,000. Finally, Global Retirement Partners LLC lifted its position in shares of Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.